Medline joins long-term care sector at Congressional Briefing 50 team members meet with legislators to advocate for support around workforce shortage
ESC Webinar: Implementation of Remote Monitoring in CIEDs in Clinical Practice WEBINAR REMOTE MONITORING ESC EVENT
JAPANESE PMDA APPROVAL FOR BIOFREEDOM™ ULTRA AND US FDA APPROVAL FOR BIOFREEDOM™ Biosensors International is pleased to announce both Japanese PMDA approval for BioFreedom™ Ultra on 31st March 2022 and also US FDA approval for BioFreedom™ on 14th April 2022.
BIOSENSORS INTERNATIONAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN NEW SEMI-COMPLIANT BALLOON TRIAL “RISE SC STUDY". This ongoing trial will evaluate the performance of the new RISETM SC balloon which will complete the Biosensors International balloon portfolio.
The Effects of Air Pollution on Heart Health STORYHEALTH & WELLNESS CARDIOLOGY INSIGHTS POLLUTION ENVIRONMENT
Announcement of co-sponsored session during CTO Club 2022 CTO Club 2022 will be held a virtual meeting from June 17th and 18th, 2022.